Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription (Q28204517)
Jump to navigation
Jump to search
scientific article (publication date: 15 February 2001)
Language | Label | Description | Also known as |
---|---|---|---|
English | Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription |
scientific article (publication date: 15 February 2001) |
Statements
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription (English)
Neckers LM
Bonvini P
An WG
Rosolen A
Nguyen P
Garcia de Herreros A
1 February 2001
Identifiers
2 references